Compare Edwards Lifesciences Corporation Common Stock (EW) vs VanEck Uranium & Nuclear ETF (NLR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs VanEck Uranium & Nuclear ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while VanEck Uranium & Nuclear ETF trades at $103.5 (market cap $3.61B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 13.7× VanEck Uranium & Nuclear ETF's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, VanEck Uranium & Nuclear ETF nearer its low. Which is the better fit depends on your goals.
| EW | NLR | |
|---|---|---|
Market Cap | $49.44B | $3.61B |
Volume | 3,508,027 | 696,289 |
Sector | Health | Sector/Thematic |
52-Week High | $95.18 | $164.37 |
52-Week Low | $72.65 | $102.38 |
Enterprise Value | $45.90B | — |
Typical Hold Time | — | 7 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About VanEck Uranium & Nuclear ETF
VanEck Uranium and Nuclear ETF seeks exposure to companies involved in uranium mining and the nuclear power industry. Its holdings may include miners, utilities, reactor-related companies, and nuclear equipment or service providers.
Read more on NLR →
